A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Completed

Conditions studied: Advanced Prostate Cancer, Prostatic Neoplasms

In brief

The purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.

Key facts

Study ID

NCT01306890

Run by

Dendreon

People needed

1976

Starts

2011-01-27

Expected to finish

2017-01-17

Last updated by the study team

2019-06-07

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• subjects must be at least 18 years of age
• subjects with advanced prostate cancer who will receive sipuleucel-T or who underwent their first leukapheresis for manufacture of sipuleucel-T ≤ 6 months prior to enrollment
• subjects must understand and sign an informed consent form

You may not qualify if…

• none

Where it is running

• Birmingham Hematology and Oncology Associates, LLC — Birmingham, Alabama, United States
• Birmingham Hematology and Oncology Associates, LLC — Birmingham, Alabama, United States
• Birmingham Hematology and Oncology Associates, LLC — Birmingham, Alabama, United States
• Birmingham Hematology and Oncology Associates, LLC — Birmingham, Alabama, United States
• Clearview Cancer Institute — Huntsville, Alabama, United States
• Ironwood Cancer and Research — Chandler, Arizona, United States
• Palo Verde Cancer Specialists — Glendale, Arizona, United States
• Weatern Regional Medical Center / Cancer Treatment Centers of America — Goodyear, Arizona, United States
• 21st Century Oncology — Scottsdale, Arizona, United States
• Pinnacle Oncology Hematology, Oncology Research Associates, PLLC — Scottsdale, Arizona, United States
• Arizona Oncology Associates, PC - HOPE — Tucson, Arizona, United States
• Arizona Oncology Associates, PC - HOPE — Tucson, Arizona, United States
• Arizona Oncology Associates, PC - HOPE — Tucson, Arizona, United States
• El Dorado Research — Tucson, Arizona, United States
• Urological Associates of Southern Arizona, P.C. — Tucson, Arizona, United States
• Little Rock Hematology Oncology: A Division of CARTI — Little Rock, Arkansas, United States
• South County Hematology/Oncology — Chula Vista, California, United States
• Wilshire Oncology Medical Group, Inc. — Corona, California, United States
• Urology Specialists of Southern California — Encino, California, United States
• Robert A. Moss, M.D., F.A.C.P., Inc — Fountain Valley, California, United States
• Pacific Shores Medical Group — Glendale, California, United States
• Wilshire Oncology Medical Group, Inc. — Glendora, California, United States
• Pacific Shores Medical Group — Huntington Beach, California, United States
• UCSD Medical Center - La Jolla — La Jolla, California, United States
• Birmingham Hematology and Oncology Associates, LLC — Bessemer, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.